Beverly Incledon
Fortune : 16 100 $ au 31/05/2026
Fortune : 16 100 $ au 31/05/2026
Dr. Beverly J.
Incledon is an Independent Director at Pharmather Holdings Ltd. She is on the Board of Directors at Pharmather Holdings Ltd. Dr. Incledon was previously employed as a Vice President-Development by Trillium Therapeutics, Inc., a President by Concept 2 Clinic, Inc., a Vice President-Research & Development by Pacgen Biopharmaceuticals Corp., a Director & Chief Scientific Officer by Ironshore Pharmaceutical & Development, Inc., a Director-Research & Development by Eli Lilly Canada, Inc., and a Vice President-Research & Development by Revive Therapeutics Ltd. She received her undergraduate degree from the University of Guelph and a doctorate degree from the University of Guelph.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/07/2025 | 350 000 ( 0,38% ) | 16 100 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PHARMATHER HOLDINGS LTD. | Directeur/Membre du Conseil | 01/06/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Ironshore Pharmaceutical & Development, Inc.
Ironshore Pharmaceutical & Development, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in research, development and distribution of drugs | Directeur Technique/Scientifique/R&D | 01/09/2024 |
Concept 2 Clinic, Inc.
Concept 2 Clinic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an executive research and development management company that specializes in pharmaceutical and biotechnology sectors | President | 01/01/2014 |
| PACGEN LIFE SCIENCE CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Corporate Officer/Principal | 01/04/2009 |
| REVIVE THERAPEUTICS LTD. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacgen Life Science Corp.
Pacgen Life Science Corp. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biomedical products and services | Health Technology |
Concept 2 Clinic, Inc.
Concept 2 Clinic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an executive research and development management company that specializes in pharmaceutical and biotechnology sectors | Commercial Services |
Revive Therapeutics Ltd.
Revive Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing, and commercializing therapeutic products | Health Technology |
Ironshore Pharmaceutical & Development, Inc.
Ironshore Pharmaceutical & Development, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in research, development and distribution of drugs | Health Technology |
PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national